Scholarlink

<p>Radiation therapy for malignant tumor patients often induces radiation enteritis (RE), a condition that impairs their quality of life. Currently, there is no standard treatment regimen available. In this study, we used lyophilized apoptotic vesicles (Lpl-apoVs) from umbilical cord mesenchymal stem cells to treat RE in a murine model. We show that enema administration of lyophilized apoVs can ameliorate intestinal damage in RE mice. Mechanistically, Lpl-apoVs were internalized by intestinal endothelial cells (IECs) to alleviate radiation-induced DNA damage. In addition, mitophagy was identified as a prerequisite for therapeutic efficacy, suggesting that rescue of DNA damage and restoration of mitochondrial quality are collaboratively to ameliorate RE diseased phenotypes. These findings indicate that enema administration of Lpl-apoVs is a novel strategy for RE therapy.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lyophilized apoptotic vesicles restore DNA damage and mitochondria dysfunction to ameliorate radiation enteritis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月16日

查看全文
  • Bo Yang,
  • Huigen Luo,
  • Xutong Yan,
  • Lingzhi Li,
  • Zhiqing Huang,
  • Yexiang Jiang,
  • Xueli Mao,
  • Songtao Shi,
  • Lan Ma

摘要

Radiation therapy for malignant tumor patients often induces radiation enteritis (RE), a condition that impairs their quality of life. Currently, there is no standard treatment regimen available. In this study, we used lyophilized apoptotic vesicles (Lpl-apoVs) from umbilical cord mesenchymal stem cells to treat RE in a murine model. We show that enema administration of lyophilized apoVs can ameliorate intestinal damage in RE mice. Mechanistically, Lpl-apoVs were internalized by intestinal endothelial cells (IECs) to alleviate radiation-induced DNA damage. In addition, mitophagy was identified as a prerequisite for therapeutic efficacy, suggesting that rescue of DNA damage and restoration of mitochondrial quality are collaboratively to ameliorate RE diseased phenotypes. These findings indicate that enema administration of Lpl-apoVs is a novel strategy for RE therapy.

Graphical Abstract